Status:

COMPLETED

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Lead Sponsor:

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Collaborating Sponsors:

Department of Nuerosurgery, Osaka Medical College

Conditions:

Brain and Central Nervous System Tumors

Eligibility:

All Genders

15-75 years

Phase:

PHASE2

Brief Summary

RATIONALE: Boron neutron capture therapy and radiation therapy use high-energy x-rays and other types of radiation to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in differ...

Detailed Description

OBJECTIVES: * Evaluate the overall survival of patients with newly diagnosed glioblastoma multiforme treated with boron neutron capture therapy, radiotherapy, and concurrent and adjuvant temozolomide...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed glioblastoma multiforme
  • Newly diagnosed disease
  • Tumor located at a supratentorial hemisphere
  • Deepest part of tumor \< 6 cm from the scalp
  • Bottom of the tumor \> 6 cm from the scalp allowed provided air instillation into tumor-removed cavity is possible
  • No cerebrospinal fluid dissemination
  • PATIENT CHARACTERISTICS:
  • Karnofsky performance status 70-100%
  • Life expectancy \> 3 months
  • Leukocyte count ≥ 3,000/μL
  • Platelet count ≥ 10.0 × 10\^4/μL
  • Hemoglobin ≥ 8.0 g/dL
  • Serum creatinine ≤ 1.5 mg/dL
  • ALT and AST ≤ 100 IU/L
  • No phenylketonuria
  • Not pregnant or nursing
  • No NYHA class III-IV heart failure
  • No patient whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator
  • PRIOR CONCURRENT THERAPY:
  • No prior chemotherapy or radiotherapy

Exclusion

    Key Trial Info

    Start Date :

    September 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 29 2016

    Estimated Enrollment :

    32 Patients enrolled

    Trial Details

    Trial ID

    NCT00974987

    Start Date

    September 1 2009

    End Date

    February 29 2016

    Last Update

    April 25 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Osaka Medical College

    Takatsuki, Osaka, Japan, 569-8686

    Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | DecenTrialz